161 related articles for article (PubMed ID: 2887518)
1. Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli.
Nakamura H; Hayami M; Ohta Y; Ishikawa K; Tsujimoto H; Kiyokawa T; Yoshida M; Sasagawa A; Honjo S
Int J Cancer; 1987 Sep; 40(3):403-7. PubMed ID: 2887518
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
3. Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6202-6. PubMed ID: 6091139
[TBL] [Abstract][Full Text] [Related]
4. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
[TBL] [Abstract][Full Text] [Related]
5. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.
Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
8. Experimental inoculation of monkeys with autologous lymphoid cell lines immortalized by and producing human T-cell leukemia virus type-I.
Nakamura H; Tanaka Y; Komuro-Tsujimoto A; Ishikawa K; Takadaya K; Tozawa H; Tsujimoto H; Honjo S; Hayami M
Int J Cancer; 1986 Dec; 38(6):867-75. PubMed ID: 2878891
[TBL] [Abstract][Full Text] [Related]
9. An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
Tu JJ; King E; Maksimova V; Smith S; Macias R; Cheng X; Vegesna T; Yu L; Ratner L; Green PL; Niewiesk S; Richner JM; Panfil AR
J Virol; 2024 Feb; 98(2):e0162323. PubMed ID: 38193692
[TBL] [Abstract][Full Text] [Related]
10. [An immunological study of human T-cell-leukemia virus type I (HTLV-I) infection (I)--Detection of low-titer anti-HTLV-I antibodies by HTLV-I associated membrane antigen (HTLV-MA) method].
Okayama A; Tachibana N; Ishizaki J; Yokota T; Shishime E; Tsuda K
Kansenshogaku Zasshi; 1987 Dec; 61(12):1363-8. PubMed ID: 2897403
[No Abstract] [Full Text] [Related]
11. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques.
Dezzutti CS; Frazier DE; Olsen RG
Dev Biol Stand; 1990; 72():287-96. PubMed ID: 2178125
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type I: pseudotype neutralization of Japanese and American isolates with human and rabbit sera.
Hoshino H; Clapham PR; Weiss RA; Miyoshi I; Yoshida M; Miwa M
Int J Cancer; 1985 Dec; 36(6):671-5. PubMed ID: 2415468
[TBL] [Abstract][Full Text] [Related]
14. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunization on HTLV-I infection in rabbits.
Takehara N; Iwahara Y; Uemura Y; Sawada T; Ohtsuki Y; Iwai H; Hoshino H; Miyoshi I
Int J Cancer; 1989 Aug; 44(2):332-6. PubMed ID: 2759739
[TBL] [Abstract][Full Text] [Related]
16. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
17. Human retroviral env and gag polypeptides: serologic assays to measure infection.
Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS
J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000
[TBL] [Abstract][Full Text] [Related]
18. Vaccine protection against HIV-2 infection in cynomolgus monkeys.
Putkonen P; Thorstensson R; Walther L; Albert J; Akerblom L; Granquist O; Wadell G; Norrby E; Biberfeld G
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):271-7. PubMed ID: 2064826
[TBL] [Abstract][Full Text] [Related]
19. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
20. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.
Tanaka Y; Tanaka R; Terada E; Koyanagi Y; Miyano-Kurosaki N; Yamamoto N; Baba E; Nakamura M; Shida H
J Virol; 1994 Oct; 68(10):6323-31. PubMed ID: 8083972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
